权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Function interactions between mitogen-activated protein kinases (MAPKs) and SARS-CoV-2

丝裂原激活蛋白激酶 (MAPK) 与 SARS-CoV-2 之间的功能相互作用

基本信息

批准号：
10659904
负责人：
Jeffrey R Johnson
金额：
$ 88.38万
依托单位：
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-03-13 至 2028-02-29
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10659904
关键词：
2019-nCoV Acute Respiratory Distress Syndrome Affect Animals Antiviral Therapy Area Bioinformatics COVID-19 pandemic COVID-19 treatment CRISPR/Cas technology Cells Cessation of life Chemicals Combined Modality Therapy Dependence Disease Disease Outcome Drug Targeting Effectiveness Family Generations Genetic Genetic Screening Genome Human Immune Immune response Infection Infiltration Inflammation Inflammatory Interleukin-6 Lung Measures Mediating Methods Mitogen-Activated Protein Kinase Inhibitor Mitogen-Activated Protein Kinases Modeling Modification Molecular Multiple Organ Failure Mutate Mutation Nucleoproteins Organoids Pathogenicity Pathway interactions Paxlovid Phenotype Phosphorylation Site Phosphotransferases Play Predisposition Production Protease Inhibitor Proteins Proteome Proteomics Recombinants Regulation Research Respiratory Failure Role SARS-CoV-2 infection SARS-CoV-2 inhibitor Signal Transduction Small Interfering RNA Technology Testing Vaccines Viral Viral Proteins Virus Replication Work base editing cytokine human stem cells in vivo interdisciplinary approach mouse model new therapeutic target nucleoside analog p38 Mitogen Activated Protein Kinase phosphoproteomics prevent recombinant virus remdesivir respiratory infection virus response severe COVID-19 small molecule stem cells tool

项目摘要

PROJECT SUMMARY SARS-CoV-2, the causative agent of the COVID-19 pandemic, modifies the cells that it infects in profound ways. One such modification is the activation of host cellular mitogen-activated protein kinase (MAPK) pathways, which contribute to severe inflammation that is a hallmark of severe COVID-19 disease. Inhibition of one MAPK pathway, the p38/MAPK pathway, reduces SARS-CoV-2 replication by an undefined mechanism. This proposal aims to measure the impact of human MAPK pathways on SARS-CoV-2 infection using a multidisciplinary approach that combines state-of-the-art proteomics technologies, medium-throughput genetic screening, and in vivo and ex vivo models of SARS-CoV-2 infection. These findings will inform the potential application of MAPK inhibitors for COVID-19 treatment and may identify alternative targets within the MAPK families. MAPK pathways play critical roles in many disease states, and this work will inform research in these areas by providing molecular mechanisms for MAPK regulation and providing tools for the unbiased discovery of MAPK substrates and regulators.

项目总结